MedPath

JOHN HOPE FRANKLIN CENTER

JOHN HOPE FRANKLIN CENTER logo
🇺🇸United States
Ownership
Private
Established
1838-01-01
Employees
5K
Market Cap
-
Website
http://www.duke.edu

Mechanisms and Functional Outcomes of Exercise Progression Models in the Elderly

Not Applicable
Completed
Conditions
Elderly
Sedentary
Interventions
Other: Regional Specific Training Stimulus (RSTS)
Other: Aerobic Exercise Regimen (AE)
First Posted Date
2013-07-15
Last Posted Date
2014-03-04
Lead Sponsor
Duke University
Target Recruit Count
108
Registration Number
NCT01899586
Locations
🇺🇸

Duke Center for Living; Wallace Clinic, Durham, North Carolina, United States

🇺🇸

Pennington Biomedical Center, Baton Rouge, Louisiana, United States

Triadic Expectations: Decision Making in the Context of Cancer Treatment

Completed
Conditions
Health Care Decision Making
First Posted Date
2013-07-12
Last Posted Date
2014-02-06
Lead Sponsor
Duke University
Target Recruit Count
38
Registration Number
NCT01898481
Locations
🇺🇸

Duke University, Durham, North Carolina, United States

Feasibility of Blood Oxygenation Level-Dependent Contrast (BOLD) Breast MRI Induced by Breath- Holding

Completed
Conditions
Breast Cancer
First Posted Date
2013-07-12
Last Posted Date
2018-08-01
Lead Sponsor
Duke University
Target Recruit Count
11
Registration Number
NCT01898533
Locations
🇺🇸

Duke University Medical Center, Durham, North Carolina, United States

Quantifying the Presence of Lung Disease and Pulmonary Hypertension in Children With Sickle Cell Disease

Phase 1
Completed
Conditions
Sickle Cell Disease
First Posted Date
2013-07-11
Last Posted Date
2014-12-03
Lead Sponsor
Duke University
Target Recruit Count
5
Registration Number
NCT01895998
Locations
🇺🇸

Duke University Medical Center, Durham, North Carolina, United States

The Early Truancy Prevention Project

Not Applicable
Completed
Conditions
Excessive Absenteeism by Primary School Students
Interventions
Behavioral: Teacher led intervention
First Posted Date
2013-07-10
Last Posted Date
2016-03-08
Lead Sponsor
Duke University
Target Recruit Count
20
Registration Number
NCT01894464
Locations
🇺🇸

Duke University, Durham, North Carolina, United States

Statin Therapy to Improve Medication Adherence

Phase 1
Completed
Conditions
HMG COA Reductase Inhibitor Adverse Reaction
Hypercholesterolemia
Interventions
Genetic: Genetic testing and reporting for SLCO1B1*5 allele
First Posted Date
2013-07-10
Last Posted Date
2015-01-08
Lead Sponsor
Duke University
Target Recruit Count
63
Registration Number
NCT01894217
Locations
🇺🇸

Duke Primary Care Clinic at Pickett Road, Durham, North Carolina, United States

🇺🇸

Duke Center for Living, Durham, North Carolina, United States

Genetically Guided Statin Therapy

Not Applicable
Completed
Conditions
Hypercholesterolemia
Hydroxy-methylglutaryl-coenzyme A (HMG Co-A) Reductase Inhibitors Adverse Reaction
Interventions
Genetic: SLCO1B1*5 allele testing, results reported at end of study
Genetic: SLCO1B1*5 allele testing, results reported at randomization
Genetic: Genetic testing for SLCO1B1*5 allele
First Posted Date
2013-07-10
Last Posted Date
2017-06-23
Lead Sponsor
Duke University
Target Recruit Count
167
Registration Number
NCT01894230
Locations
🇺🇸

David Grant US Air Force Medical Center, Travis Air Force Base, California, United States

🇺🇸

Duke University, Durham, North Carolina, United States

Immunotherapy With CEA(6D) VRP Vaccine (AVX701) in Patients With Stage III Colorectal Cancer

Phase 1
Completed
Conditions
Stage III Colon Cancer
Interventions
Biological: AVX701
First Posted Date
2013-07-01
Last Posted Date
2019-07-18
Lead Sponsor
Duke University
Target Recruit Count
12
Registration Number
NCT01890213
Locations
🇺🇸

Duke University Medical Center, Durham, North Carolina, United States

Freezing of Gait in Parkinson's Disease

Not Applicable
Completed
Conditions
Parkinson Disease
Interventions
Other: Placebo group - non use of Tower of Hanoi
Device: Tower of Hanoi
First Posted Date
2013-06-26
Last Posted Date
2017-01-24
Lead Sponsor
Duke University
Target Recruit Count
30
Registration Number
NCT01887054
Locations
🇺🇸

Duke University Medical Center, Durham, North Carolina, United States

Safety and Efficacy of Albuterol in Individuals With Late-onset Pompe Disease

Phase 1
Completed
Conditions
Pompe Disease
Interventions
Drug: Placebo
Drug: Albuterol
First Posted Date
2013-06-25
Last Posted Date
2019-07-15
Lead Sponsor
Duke University
Target Recruit Count
16
Registration Number
NCT01885936
Locations
🇺🇸

Duke University Medical Center, Durham, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath